Evidence map›Paper›PMID 35709646›Full record

ArticleSchizophrenia research2022

Age-dependent patterns of schizophrenia genetic risk affect cognition.

Susan S Kuo, Christie W Musket, Petra E Rupert, Laura Almasy, Ruben C Gur, Konasale M Prasad, David R Roalf, Raquel E Gur, Vishwajit L Nimgaonkar, Michael F Pogue-Geile

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Cognitive impairment in adolescent and adult-onset psychosis: a comparative study.Child and adolescent psychiatry and mental health · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Susan S KuoDepartment of Psychology, University of Pittsburgh, United States of America; Stanley Center for Psychiatric Genetics, Broad Institute of MIT and Harvard, United States of America; Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School, United States of America.
Christie W MusketDepartment of Psychology, University of Pittsburgh, United States of America.
Petra E RupertDepartment of Psychology, University of Pittsburgh, United States of America.
Laura AlmasyDepartment of Genetics, University of Pennsylvania, United States of America.
Ruben C GurDepartment of Psychiatry, University of Pennsylvania, United States of America.
Konasale M PrasadDepartment of Psychiatry, University of Pittsburgh, United States of America; Department of Bioengineering, University of Pittsburgh, United States of America; Veteran Affairs Pittsburgh Healthcare System, United States of America.
David R RoalfDepartment of Psychiatry, University of Pennsylvania, United States of America.
Raquel E GurDepartment of Psychiatry, University of Pennsylvania, United States of America.
Vishwajit L NimgaonkarDepartment of Psychiatry, University of Pittsburgh, United States of America; Department of Human Genetics, University of Pittsburgh, United States of America.
Michael F Pogue-GeileDepartment of Psychology, University of Pittsburgh, United States of America; Department of Psychiatry, University of Pittsburgh, United States of America. Electronic address: mfpg@pitt.edu.
University of Pennsylvania · USUniversity of Pittsburgh · USBroad Institute · USVA Pittsburgh Healthcare System · US

Funding

NEUROBEHAVIORAL STUDY OF SCHIZOPHRENIAR01MH042191 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 1987 to 2018
$7.1M
A Neurobehavioral Family Study of SchizophreniaR01MH063480 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NIMGAONKAR, VISHWAJIT LAXMIKANT · 2001 to 2018
$6.1M
A Neurobehavioral Family Study of SchizophreniaR01MH061622 · NIMH · UNIVERSITY OF TEXAS RIO GRANDE VALLEY · PI ALMASY, LAURA A. · 2001 to 2018
$4.9M
The Neurobiology of Affective Dysfunction in SchizophreniaR01MH060722 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RUBEN C. · 2001 to 2010
$4.8M
Predoctoral Training Program in Behavioral Brain ResearchT32GM081760 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI FIEZ, JULIE A, HOLT, LORI L · 2007 to 2021
$4.3M
Ultra-high field GluCEST MRI and MRS in youth at risk for psychosisR01MH120174 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2020 to 2024
$3.8M
Olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndromeR01MH119185 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2019 to 2024
$3.5M
NIGMS NIH HHS T32 GM081760NIMH NIH HHS R01 MH042191NIMH NIH HHS R01 MH060722NIMH NIH HHS R01 MH061622NIMH NIH HHS R01 MH063480NIMH NIH HHS R01 MH119185NIMH NIH HHS R01 MH120174
6 · The paper itself

Abstract

Cognition shares substantial genetic overlap with schizophrenia, yet it remains unclear whether such genetic effects become significant during developmental periods of elevated risk for schizophrenia, such as the peak age of onset. We introduce an investigative framework integrating epidemiological, developmental, and genetic approaches to determine whether genetic effects shared between schizophrenia and cognition are significant across periods of differing risk for schizophrenia onset, and whether these effects are shared with depression. 771 European-American participants, including 636 (ages 15-84 years) from families with at least two first-degree relatives with schizophrenia and 135 unrelated controls, were divided into three age-risk groups based on ages relative to epidemiological age of onset patterns for schizophrenia: Pre-Peak (before peak age-of-onset: 15 to 22 years), Post-Peak (after peak age-of-onset: 23-42 years), and Plateau (during plateau of age-of-onset: over 42 years). For general cognition and 11 specific cognitive traits, we estimated genetic correlations with schizophrenia and with depression within each age-risk group. Genetic effects shared between deficits in general cognition and schizophrenia were nonsignificant before peak age of onset, yet were high and significant after peak age of onset and during the plateau of onset. These age-dependent genetic effects were largely consistent across specific cognitive traits and not transdiagnostically shared with depression. Schizophrenia genetic effects appear to influence cognitive traits in an age-dependent manner, supporting late developmental and perhaps neurodegenerative models that hypothesize increased expression of schizophrenia risk genes during and after the peak age of risk. Our findings underscore the utility of cognitive traits for tracking schizophrenia genetic effects across the lifespan.

Indexed as

SchizophreniaAdolescentAdultAgedAged, 80 and overCognitionHumansMiddle AgedPhenotypeRisk FactorsYoung AdultAge of onsetClinical high riskDevelopmental riskHeritabilityPsychiatric geneticsPsychosis

Identifiers

PMID35709646
PMCPMC11227884
OpenAlexW4282590980

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.